{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T21:40:04Z","timestamp":1782337204927,"version":"3.54.5"},"reference-count":34,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medicina Cl\u00ednica"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.medcli.2025.106941","type":"journal-article","created":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T08:49:11Z","timestamp":1745311751000},"page":"106941","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Effects of six months treatment with liraglutide among patients with psoriasis and obesity, beyond metabolic control?"],"prefix":"10.1016","volume":"164","author":[{"given":"Joana","family":"Nicolau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoni","family":"Nadal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"Sanch\u00eds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antelm","family":"Pujol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Isabel","family":"Tamayo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Nadal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Llu\u00eds","family":"Masmiquel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.medcli.2025.106941_bib0175","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(20)32549-6","article-title":"Psoriasis","volume":"397","author":"Griffiths","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.medcli.2025.106941_bib0180","doi-asserted-by":"crossref","first-page":"e1002739","DOI":"10.1371\/journal.pmed.1002739","article-title":"Evidence of a causal relationship between body mass index and psoriasis: a Mendelian randomization study","volume":"16","author":"Budu-Aggrey","year":"2019","journal-title":"PLoS Med"},{"key":"10.1016\/j.medcli.2025.106941_bib0185","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s13679-020-00380-3","article-title":"Deciphering the association between psoriasis and obesity: current evidence and treatment considerations","volume":"9","author":"Paroutoglou","year":"2020","journal-title":"Curr Obes Rep"},{"key":"10.1016\/j.medcli.2025.106941_bib0190","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1001\/jamadermatol.2013.722","article-title":"Effect of weight loss on the severity of psoriasis: a randomized clinical study","volume":"149","author":"Jensen","year":"2013","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.medcli.2025.106941_bib0195","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ad.2012.08.003","article-title":"Obesity and psoriasis: inflammatory nature of obesity, relationship between psoriasis and obesity, and therapeutic implications","volume":"105","author":"Carrascosa","year":"2014","journal-title":"Actas Dermosifiliogr"},{"key":"10.1016\/j.medcli.2025.106941_bib0200","first-page":"663","article-title":"Relationship between psoriasis and metabolic syndrome: a systematic review","volume":"151","author":"Singh","year":"2016","journal-title":"G Ital Dermatol Venereol"},{"key":"10.1016\/j.medcli.2025.106941_bib0205","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jbspin.2018.03.007","article-title":"Impact of obesity on the efficacy of different biologic agents in inflammatory diseases: a systematic review and meta-analysis","volume":"86","author":"Shan","year":"2019","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.medcli.2025.106941_bib0210","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/jdv.14517","article-title":"Recommendations for the management of comorbidity in hidradenitis suppurativa","volume":"32","author":"Dauden","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.medcli.2025.106941_bib0215","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1038\/ijo.2015.64","article-title":"Effect of lifestyle weight loss intervention on disease severity in patients with psoriasis: a systematic review and meta-analysis","volume":"39","author":"Upala","year":"2015","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/j.medcli.2025.106941_bib0220","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ad.2018.05.009","article-title":"Psoriasis and depression: the role of inflammation","volume":"110","author":"Gonz\u00e1lez-Parra","year":"2019","journal-title":"Actas Dermosifiliogr (Engl Ed)"},{"key":"10.1016\/j.medcli.2025.106941_bib0225","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.clindermatol.2017.09.005","article-title":"Psoriasis and the metabolic syndrome","volume":"36","author":"Gisondi","year":"2018","journal-title":"Clin Dermatol"},{"issue":"Suppl. 1","key":"10.1016\/j.medcli.2025.106941_bib0230","first-page":"74","article-title":"Nutritional ultrasound\u00ae: conceptualisation, technical considerations and standardisation","volume":"70","author":"Garc\u00eda-Almeida","year":"2023","journal-title":"Endocrinol Diabetes Nutr (Engl Ed)"},{"key":"10.1016\/j.medcli.2025.106941_bib0235","doi-asserted-by":"crossref","first-page":"4331","DOI":"10.1210\/jc.2010-0061","article-title":"High prevalence of growth hormone deficiency in severe fibromyalgia syndromes","volume":"95","author":"Cuatrecasas","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.medcli.2025.106941_bib0240","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1089\/aid.2021.0141","article-title":"Ultrasound-based assessment of preperitoneal fat as a surrogate marker of cardiovascular risk: comparative study between people living with HIV and controls","volume":"38","author":"Bonjoch","year":"2022","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1016\/j.medcli.2025.106941_bib0245","first-page":"130","article-title":"The SEEN comprehensive clinical survey of adult obesity: executive summary","volume":"68","author":"Ballesteros Pomar","year":"2021","journal-title":"Endocrinol Diabetes Nutr (Engl Ed)"},{"key":"10.1016\/j.medcli.2025.106941_bib0250","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1038\/ijo.2013.162","article-title":"Effects of the once-daily GLP-1 analog liraglutide on gastric emptying, glycemic parameters, appetite and energy metabolism in obese, non-diabetic adults","volume":"38","author":"van Can","year":"2014","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/j.medcli.2025.106941_bib0255","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1038\/ijo.2013.120","article-title":"Weight maintenance and additional weight loss with liraglutide after low-calorie-diet-induced weight loss: the SCALE Maintenance randomized study","volume":"37","author":"Wadden","year":"2013","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/j.medcli.2025.106941_bib0260","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/oby.22726","article-title":"Liraglutide 3.0mg and intensive behavioral therapy (IBT) for obesity in primary care: the SCALE IBT randomized controlled trial","volume":"28","author":"Wadden","year":"2020","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.medcli.2025.106941_bib0265","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1111\/j.1468-3083.2012.04609.x","article-title":"Glucagon-like peptide-1 analogue therapy for psoriasis patients with obesity and type 2 diabetes: a prospective cohort study","volume":"27","author":"Ahern","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.medcli.2025.106941_bib0270","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/bjd.12886","article-title":"Improvement of psoriasis during glucagon-like peptide-1 analogue therapy in type 2 diabetes is associated with decreasing dermal \u03b3\u03b4 T-cell number: a prospective case-series study","volume":"171","author":"Buysschaert","year":"2014","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.medcli.2025.106941_bib0275","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/jdv.12629","article-title":"Lack of effect of the glucagon-like peptide-1 receptor agonist liraglutide on psoriasis in glucose-tolerant patients \u2013 a randomized placebo-controlled trial","volume":"29","author":"Faurschou","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.medcli.2025.106941_bib0280","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1080\/09546634.2021.1882658","article-title":"Efficacy of GLP-1rA, liraglutide, in plaque psoriasis treatment with type 2 diabetes: a systematic review and meta-analysis of prospective cohort and before-after studies","volume":"33","author":"Chang","year":"2022","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.medcli.2025.106941_bib0285","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.medcli.2023.05.021","article-title":"Effects of liraglutide among patients living with psoriasis and obesity","volume":"161","author":"Nicolau","year":"2023","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.medcli.2025.106941_bib0290","unstructured":"National Institute for Health and Care Excellence. Psoriasis: assessment and management. Available from: https:\/\/www.nice.org.uk\/guidance\/cg153\/s.f."},{"key":"10.1016\/j.medcli.2025.106941_bib0295","first-page":"692","article-title":"Adaptaci\u00f3n transcultural al espa\u00f1ol del cuestionario Dermatology Life Quality Index (DLQI): El \u00cdndice de Calidad de Vida en Dermatolog\u00eda","volume":"89","author":"de Tiedra","year":"1998","journal-title":"Actas Dermo-Sifiliogr"},{"key":"10.1016\/j.medcli.2025.106941_bib0300","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/hep.24013","article-title":"Noninvasive assessment of liver fibrosis","volume":"53","author":"Mart\u00ednez","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.medcli.2025.106941_bib0305","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1007\/s11695-012-0682-4","article-title":"Validity of the Beck Depression Inventory as a screening tool for a clinical mood disorder in bariatric surgery candidates","volume":"22","author":"Hayden","year":"2012","journal-title":"Obes Surg"},{"key":"10.1016\/j.medcli.2025.106941_bib0310","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1007\/s10654-018-0366-z","article-title":"Body mass index, abdominal fatness, weight gain and the risk of psoriasis: a systematic review and dose\u2013response meta-analysis of prospective studies","volume":"33","author":"Aune","year":"2018","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.medcli.2025.106941_bib0315","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1111\/bjd.17741","article-title":"Does weight loss reduce the severity and incidence of psoriasis or psoriatic arthritis? A critically appraised topic","volume":"181","author":"Mahil","year":"2019","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.medcli.2025.106941_bib0320","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1056\/NEJMoa2307563","article-title":"Semaglutide and cardiovascular outcomes in obesity without diabetes","volume":"389","author":"Lincoff","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.medcli.2025.106941_bib0325","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1177\/2042018814543483","article-title":"Effect of glucagon-like peptide-1 receptor agonists in patients with psoriasis","volume":"5","author":"Al-Badri","year":"2014","journal-title":"Ther Adv Endocrinol Metab"},{"key":"10.1016\/j.medcli.2025.106941_bib0330","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ad.2023.06.017","article-title":"Glucagon-like peptide-1 agonists for treating obesity in patients with immune-mediated skin diseases","volume":"115","author":"Vilarrasa","year":"2024","journal-title":"Actas Dermosifiliogr"},{"key":"10.1016\/j.medcli.2025.106941_bib0335","first-page":"21","article-title":"Two birds one stone: semaglutide is highly effective against severe psoriasis in a type 2 diabetic patient","volume":"2021","author":"Costanzo","year":"2021","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"key":"10.1016\/j.medcli.2025.106941_bib0340","article-title":"Semaglutide therapy decreases epicardial fat inflammation and improves psoriasis severity in patients affected by abdominal obesity and type-2 diabetes","volume":"2023","author":"Malavazos","year":"2023","journal-title":"Endocrinol Diabetes Metab Case Rep"}],"container-title":["Medicina Cl\u00ednica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775325001472?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775325001472?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T16:15:17Z","timestamp":1749226517000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025775325001472"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":34,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S0025775325001472"],"URL":"https:\/\/doi.org\/10.1016\/j.medcli.2025.106941","relation":{},"ISSN":["0025-7753"],"issn-type":[{"value":"0025-7753","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of six months treatment with liraglutide among patients with psoriasis and obesity, beyond metabolic control?","name":"articletitle","label":"Article Title"},{"value":"Medicina Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medcli.2025.106941","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Espa\u00f1a, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106941"}}